Search

everythinglearnresearchcommunity

for

Search:↓

Enz_MoriL from mulberry leaves helps hair growth by affecting specific cell pathways.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Patients with central centrifugal cicatricial alopecia often have higher rates of metabolic, autoimmune, and atopic conditions, as well as anxiety and depression.

Alopecia areata is a complex condition causing hair loss, linked to genetics and immune system issues, and may be related to other autoimmune diseases; treatments vary in effectiveness.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Baricitinib is a promising treatment for alopecia areata.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Stem cells and their secretions could potentially treat stress-induced hair loss, but more human trials are needed.

MS patients often have skin issues, so regular skin checks are important.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Dupilumab can help hair regrowth but may also trigger alopecia areata.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Not getting enough vitamin D can lead to health problems, so kids over one should get 600 IU/day.

Targeting IL-17 could help treat pattern hair loss.

Microneedle patches improve drug delivery for skin treatments and cosmetic enhancements.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Thyroid hormones are important for skin health and might help treat skin diseases, but more research is needed to understand their effects fully.

Leflunomide is more likely to help treat alopecia areata than cause it.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.